Jamie Lopez
Clinical Oncology Society of Australia Annual Scientific Meeting 2017
Days
Sunday, 12th November
Monday, 13th November
Tuesday, 14th November
Wednesday, 15th November
Search
Speakers
Jamie Lopez
Abstracts this author is presenting:
Initial efficacy of anti-lymphocyte activation gene-3 (anti–LAG-3; BMS-986016) in combination with nivolumab in patients with melanoma who progressed during prior anti–PD-1/PD-L1 therapy
—
Poster Session 1
Three-year follow-up from checkMate 017/057: Nivolumab versus Docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC)
—
Poster Session 1